Back
Capricor Therapeutics Stock Price Chart
Economic Policy Shifts = Huge Market Opportunity
See which of your stocks make the grade - analyze 3 stocks FREE.
Buy
61
CAPR
Capricor Therapeutics
Last Price:
$14.24
Seasonality Move:
13.79%
7 Day Trial
ALL ACCESS PASS
$
7
Here's the Best Day to Buy Nvidia
Click here to see the green days for 5 major stocks today.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CAPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Capricor Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11 | Buy |
| 20-day SMA: | 9.8 | Buy |
| 50-day SMA: | 10.35 | Buy |
| 200-day SMA: | 12.81 | Buy |
| 8-day EMA: | 11.35 | Buy |
| 20-day EMA: | 10.63 | Buy |
| 50-day EMA: | 10.86 | Buy |
| 200-day EMA: | 11.4 | Buy |
Capricor Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.4 | Buy |
| Relative Strength Index (14 RSI): | 66.22 | Buy |
| Chaikin Money Flow: | 1454200 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.88 - 11.72) | Buy |
| Bollinger Bands (100): | (9.8 - 14.56) | Buy |
Capricor Therapeutics Technical Analysis
| May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 22 | 23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Capricor Therapeutics Stock
Is Capricor Therapeutics Stock a Buy?
-
Capricor Therapeutics share price is 13.18 while CAPR 8-day simple moving average is 11.00, which is a Buy signal.
-
The stock price of CAPR is 13.18 while Capricor Therapeutics 20-day SMA is 9.80, which makes it a Buy.
-
Capricor Therapeutics 50-day simple moving average is 10.35 while CAPR share price is 13.18, making it a Buy technically.
-
CAPR stock price is 13.18 and Capricor Therapeutics 200-day simple moving average is 12.81, creating a Buy signal.
CAPR Technical Analysis vs Fundamental Analysis
Buy
61
Capricor Therapeutics (CAPR)
is a Buy
Is Capricor Therapeutics a Buy or a Sell?
-
Capricor Therapeutics stock is rated a BuyThe current Capricor Therapeutics [CAPR] share price is $13.18. The Score for CAPR is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
Capricor Therapeutics Stock Info
Market Cap:
602.4M
Price in USD:
13.18
Share Volume:
2.6M
Capricor Therapeutics 52-Week Range
52-Week High:
23.40
52-Week Low:
3.52
Buy
61
Capricor Therapeutics (CAPR)
is a Buy
Capricor Therapeutics Share Price Forecast
-
What is the Capricor Therapeutics stock price today?The Capricor Therapeutics stock price is 13.18 USD today.
-
Will CAPR stock go up or go down?Capricor Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Capricor Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Capricor Therapeutics is not overvalued.
Is Capricor Therapeutics Stock a Buy?
-
Capricor Therapeutics share price is 13.18 while CAPR 8-day exponential moving average is 11.35, which is a Buy signal.
-
The stock price of CAPR is 13.18 while Capricor Therapeutics 20-day EMA is 10.63, which makes it a Buy.
-
Capricor Therapeutics 50-day exponential moving average is 10.86 while CAPR share price is 13.18, making it a Buy technically.
-
CAPR stock price is 13.18 and Capricor Therapeutics 200-day simple moving average is 11.40, creating a Buy signal.
Fundamental Analysis of Capricor Therapeutics
Is Capricor Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.93 per share, a decrease next quarter of $0.89 per share, an increase this year of $1.68 per share, and a decrease next year of $1.30 per share.
Technical Analysis of Capricor Therapeutics
Should I short Capricor Therapeutics stock?
-
CAPR Moving Average Covergence Divergence (MACD) indicator is 0.4, suggesting Capricor Therapeutics is a Buy
-
Capricor Therapeutics Relative Strength Index (RSI) is 66.22, which suggest Capricor Therapeutics is overbought
-
The Bollinger Bands (25) for Capricor Therapeutics is (7.88 - 11.72), which suggest Capricor Therapeutics is a Buy
-
The Bollinger Bands (100) for Capricor Therapeutics is (9.8 - 14.56), which suggest Capricor Therapeutics is a Buy
* Capricor Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.